Recursion Pharmaceuticals
Doo-Hyun Kwon is an accomplished scientist specializing in theoretical chemistry, holding a Ph.D. from Brigham Young University, where studies were completed between 2014 and 2019. Kwon has held significant positions in various organizations, currently serving as an Associate Principal Scientist at Recursion since May 2023. Prior experience includes roles as a Senior Scientist at Proteovant Therapeutics from April 2022 to May 2023 and as an Investigator in Computational Chemistry and Molecular Design at GSK from August 2019 to April 2022. Earlier career experience comprises serving as a Graduate Student Research Assistant at Brigham Young University and as a Research Student at the University of Utah College of Science.
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.